AIP
PROK icon

Ameritas Investment Partners’s ProKidney PROK Stock Holding History

Ameritas Investment Partners’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,523
Closed -$9.22K – 3308
2025
Q1 		$9.22K Hold
10,523
– – ﹤0.01% 2846
2024
Q4 		$17.8K Hold
10,523
– – ﹤0.01% 2682
2024
Q3 		$20.2K Buy
10,523
+6,013
+133% +$13.7K ﹤0.01% 2651
2024
Q2 		$11.1K Hold
4,510
– – ﹤0.01% 2884
2024
Q1 		$7.4K Hold
4,510
– – ﹤0.01% 2889
2023
Q4 		$8.03K Hold
4,510
– – ﹤0.01% 2899
2023
Q3 		$20.7K Sell
4,510
-585
-11% -$5.6K ﹤0.01% 2520
2023
Q2 		$57K Buy
+5,095
New +$54.2K ﹤0.01% 1969

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameritas Investment Partners's PROK Position: Q2 2025 in Review

Ameritas Investment Partners sold out of ProKidney (PROK) in Q2 2025, closing a stake of 10,523 shares — an estimated $9.22K sold.

Ameritas Investment Partners first reported a position in PROK in Q2 2023 and held it in 8 quarters. The position peaked at $57K in Q2 2023. 56 funds tracked by Wall St. Rank hold PROK as of Q2 2025.

  • Ameritas Investment Partners reported no remaining ProKidney position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 10,523 ProKidney shares in Q2 2025, an estimated $9.22K.
  • Ameritas Investment Partners first reported a position in ProKidney in Q2 2023 and held it in 8 quarters.
  • Ameritas Investment Partners's ProKidney position peaked at $57K in Q2 2023.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.